Taysha Gene Therapies (NASDAQ:TSHA) highlighted clinical, regulatory, and commercial progress for its lead Rett syndrome gene ...
IG Group (LON:IGG) executives told investors the company delivered “record” results in 2025, with management highlighting accelerating customer growth, expanding product capability, and continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results